Akdas S, Yuksel D, Yazihan N (2024) Assessment of the relationship between amino acid status and Parkinson’s disease: a comprehensive review and meta-analysis. Can J Neurol Sci 2024:1–17

Article  Google Scholar 

Ambeskovic M, Hopkins G, Hoover T, Joseph JT, Metz GAS (2023) Metabolomic signatures of alzheimer’s disease indicate brain Region-Specific neurodegenerative progression. Int J Mol Sci 24:14769

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aquilani R, Costa A, Maestri R, Cotta Ramusino M, Pierobon A, Dossena M, Solerte SB, Condino AM, Torlaschi V, Bini P (2020) Mini nutritional assessment may identify a dual pattern of perturbed plasma amino acids in patients with alzheimer’s disease: a window to metabolic and physical rehabilitation? Nutrients 12:1845

Article  CAS  PubMed  PubMed Central  Google Scholar 

Batra R, Krumsiek J, Wang X, Allen M, Blach C, Kastenmüller G, Arnold M, Ertekin-Taner N, Kaddurah-Daouk R, Alzheimer’s Disease Metabolomics Consortium (2024) Comparative brain metabolomics reveals shared and distinct metabolic alterations in Alzheimer’s disease and progressive supranuclear palsy. Alzheimer’s Dement 20:8294–307

Article  CAS  Google Scholar 

Botello-Marabotto M, Martínez-Bisbal MC, Calero M, Bernardos A, Pastor AB, Medina M, Martínez-Máñez R (2023) Non-invasive biomarkers for mild cognitive impairment and Alzheimer’s disease. Neurobiol Dis 187:106312

Article  CAS  PubMed  Google Scholar 

Chen Y, Wang Y, Song Z, Fan Y, Gao T, Tang X (2023) Abnormal white matter changes in alzheimer’s disease based on diffusion tensor imaging: A systematic review. Ageing Res Rev 87:101911

Article  PubMed  Google Scholar 

Cheng J-Y, Deng Y-T, Yu J-T (2023) The causal role of Circulating amino acids on neurodegenerative disorders: A two‐sample Mendelian randomization study. J Neurochem 166:972–981

Article  CAS  PubMed  Google Scholar 

de Oliveira Souza IN, Roychaudhuri R, de Belleroche J, Mothet J-P (2023) d-Amino acids: new clinical pathways for brain diseases. Trends Mol Med 29:1014–1028

Article  Google Scholar 

Faldu KG, Shah JS (2022) Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis. Expert Rev Mol Diagn 22:681–703

Article  CAS  PubMed  Google Scholar 

Fan X, Cai Y, Zhao L, Liu W, Luo Y, Au LWC, Shi L, Tong Mok VC (2024) Machine Learning-Derived MRI-Based neurodegeneration biomarker for alzheimer’s disease: A Multi-Database validation study. J Alzheimer’s Disease 97:883–893

Article  CAS  Google Scholar 

Fu Y, Wang Y, Ren H, Guo X, Han L (2024) Branched-chain amino acids and the risks of dementia, alzheimer’s disease, and parkinson’s disease. Front Aging Neurosci 16:1369493

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fujita S (2024) Optimizing strategies to prevent cognitive decline with 20-Year brain imaging. JAMA Netw Open 7:e2441466–e66

Article  PubMed  Google Scholar 

Gika HG, Theodoridis GA, Plumb RS, Wilson ID (2014) Current practice of liquid chromatography-mass spectrometry in metabolomics and metabonomics. J Pharm Biomed Anal 87:12–25

Article  CAS  PubMed  Google Scholar 

González Zarzar T, Lee B, Coughlin R, Kim D, Shen L, Hall MA (2022) Sex differences in the metabolome of alzheimer’s disease progression. Front Radiol 2:782864

Article  PubMed Central  Google Scholar 

Gueli MC, Taibi G (2013) Alzheimer’s disease: amino acid levels and brain metabolic status. Neurol Sci 34:1575–1579

Article  PubMed  Google Scholar 

Ibáñez C, Simó C, Martín-Álvarez PJ, Kivipelto M, Winblad B, Cedazo-Mínguez A, Cifuentes A (2012) Toward a predictive model of Alzheimer’s disease progression using capillary electrophoresis-mass spectrometry metabolomics. Anal Chem 84:8532–40

Article  PubMed  Google Scholar 

Ikeuchi T, Kanda M, Kitamura H, Morikawa F, Toru S, Nishimura C, Kasuga K, Tokutake T, Takahashi T, Kuroha Y (2022) Decreased Circulating branched-chain amino acids are associated with development of alzheimer’s disease in elderly individuals with mild cognitive impairment. Front Nutr 9:1040476

Article  PubMed  PubMed Central  Google Scholar 

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Budd Haeberlein S, Holtzman DM, Jagust W, Jessen F, Karlawish J (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement 14:535–62

Article  Google Scholar 

Kim M, Song YS, Han K, Bae YJ, Han JW, Kim KW (2024) Impaired glymphatic flow on diffusion tensor MRI as a marker of neurodegeneration in alzheimer’s disease: correlation with Gray matter volume loss and cognitive decline independent of cerebral amyloid deposition. J Alzheimer’s Disease 99:279–290

Article  CAS  Google Scholar 

Lella C, Nestor L, De Bundel D, Vander Heyden Y, Van Eeckhaut A (2024) Targeted chiral metabolomics of D-Amino acids: their emerging role as potential biomarkers in neurological diseases with a focus on their liquid Chromatography–Mass spectrometry analysis upon chiral derivatization. Int J Mol Sci 25:12410

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu M, Li M, He J, He Y, Yang J, Sun Z (2023) Chiral amino acid profiling in serum reveals potential biomarkers for alzheimer’s disease. J Alzheimer’s Disease 94:291–301

Article  CAS  Google Scholar 

Lopez-Lee C, Torres ERS, Carling G, Gan L (2024) Mechanisms of sex differences in Alzheimer’s disease. Neuron. 112(8):1208–21

Article  CAS  PubMed  PubMed Central  Google Scholar 

McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on alzheimer’s disease. Neurology 34:939–944

Article  CAS  PubMed  Google Scholar 

Mehdipour Ghazi M, Selnes P, Timón-Reina S, Tecelão S, Ingala S, Bjørnerud A, Kirsebom B-E, Fladby T, Nielsen M (2024) Comparative analysis of multimodal biomarkers for amyloid-beta positivity detection in Alzheimer’s disease cohorts. Front Aging Neurosci 16:1345417

Article  PubMed  PubMed Central  Google Scholar 

Müller H-P, Kassubek J (2024) Toward diffusion tensor imaging as a biomarker in neurodegenerative diseases: technical considerations to optimize recordings and data processing. Front Hum Neurosci 18:1378896

Article  PubMed  PubMed Central  Google Scholar 

Ni X, Mori H (2022) Complex processes underlying the dynamic changes of D-serine levels in AD brains. Curr Alzheimer Res 19:485–493

Article  CAS  PubMed  Google Scholar 

Nielsen JE, Andreassen T, Gotfredsen CH, Olsen DA, Vestergaard K, Madsen JS, Kristensen SR, Pedersen S (2024) Serum metabolic signatures for Alzheimer’s Disease reveal alterations in amino acid composition: a validation study. Metabolomics 20:12

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palmeira ALR, Fernandez LL, Pachado MP, de Paula LM, Fontela C, Gil Oliveira T, Eller S (2024) ’Blood-based plasmatic aminoacid profiles as potential biomarkers for dementia. Alzheimer’sDement 20:e093365

Article  Google Scholar 

Patil DR, Patil PK, Sunila AP (2024) A review on UHPLC method. Res J Pharmacol Pharmacodynamics 16:123–126

Article  Google Scholar 

Petersen RC, Aisen PS, Beckett LA, Donohue MC, Gamst AC, Harvey DJ, Jack CR Jr., Jagust WJ, Shaw LM, Toga AW, Trojanowski JQ, Weiner MW (2010) Alzheimer’s disease neuroimaging initiative (ADNI): clinical characterization. Neurology 74:201–209

Article  PubMed  PubMed Central  Google Scholar 

Raghavan S, Przybelski SA, Reid RI, Graff-Radford J, Lesnick TG, Zuk SM, Knopman DS, Machulda MM, Mielke MM, Petersen RC (2020) Reduced fractional anisotropy of the genu of the corpus callosum as a cerebrovascular disease marker and predictor of longitudinal cognition in MCI. Neurobiol Aging 96:176–83

Article  CAS  PubMed  PubMed Central  Google Scholar 

Raghavan S, Reid RI, Przybelski SA, Timothy G, Lesnick J, Graff-Radford CG, Schwarz S, Knopman DS, Mielke MM, Machulda MM, Petersen RC (2021) Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition. Brain Commun 3:fcab106

Article